INTRODUCTION: There is a lack of data on physical activity (PA) and fitness of adolescent and young adult very long-term survivors of childhood acute lymphoblastic leukemia (ALL). METHODS: We studied 21 childhood ALL long-term survivors (aged 16-30 years, median time since diagnosis 15.9 y), diagnosed in 1986-1996, with age- and sex-matched controls. Peak oxygen uptake (VO(2 peak)) and muscle strength were measured and physical activity index (PAI; MET h/week) calculated. RESULTS: Mean VO(2 peak) of the ALL survivors was 34.8 ± 9.3 ml/kg/min. This was 14% lower than that of the controls (-5.7 ml/kg/min, 95% CI -9.4 to -1.9, p=0.01), and all the 11 female survivors performed below the age-adjusted reference values. The survivors also performed poorer in the sit-up and maximal jump tests (p=0.02 and p=0.004). Body mass index and PAI were similar in survivors and controls (p=0.34 and p=0.52). Nonetheless, as much as 30% of the male survivors and 36% of the female survivors had PAI ≤ 5 indicating very low levels of physical activity (PA). CONCLUSIONS: Insufficient PA and poor physical fitness are clinically important issues in childhood ALL long-term survivors treated with modern protocols. Girls seem to be especially at risk. PA and better physical fitness decrease cardiovascular mortality irrespective of weight. Thus, PA should be promoted throughout and after the treatment for ALL. IMPLICATIONS FOR CANCER SURVIVORS: Since insufficient PA and poor physical fitness are an issue in very long-term ALL survivors, they should be informed on the benefits of physical activity, and be strongly encouraged to adopt a physically active lifestyle.
INTRODUCTION: There is a lack of data on physical activity (PA) and fitness of adolescent and young adult very long-term survivors of childhood acute lymphoblastic leukemia (ALL). METHODS: We studied 21 childhood ALL long-term survivors (aged 16-30 years, median time since diagnosis 15.9 y), diagnosed in 1986-1996, with age- and sex-matched controls. Peak oxygen uptake (VO(2 peak)) and muscle strength were measured and physical activity index (PAI; MET h/week) calculated. RESULTS: Mean VO(2 peak) of the ALL survivors was 34.8 ± 9.3 ml/kg/min. This was 14% lower than that of the controls (-5.7 ml/kg/min, 95% CI -9.4 to -1.9, p=0.01), and all the 11 female survivors performed below the age-adjusted reference values. The survivors also performed poorer in the sit-up and maximal jump tests (p=0.02 and p=0.004). Body mass index and PAI were similar in survivors and controls (p=0.34 and p=0.52). Nonetheless, as much as 30% of the male survivors and 36% of the female survivors had PAI ≤ 5 indicating very low levels of physical activity (PA). CONCLUSIONS:Insufficient PA and poor physical fitness are clinically important issues in childhood ALL long-term survivors treated with modern protocols. Girls seem to be especially at risk. PA and better physical fitness decrease cardiovascular mortality irrespective of weight. Thus, PA should be promoted throughout and after the treatment for ALL. IMPLICATIONS FOR CANCER SURVIVORS: Since insufficient PA and poor physical fitness are an issue in very long-term ALL survivors, they should be informed on the benefits of physical activity, and be strongly encouraged to adopt a physically active lifestyle.
Authors: Marco van Brussel; Tim Takken; Janjaap van der Net; Raoul H H Engelbert; Marc Bierings; Marja A G C Schoenmakers; Paul J M Helders Journal: Pediatr Rehabil Date: 2006 Jul-Sep
Authors: Marjaana Lahti-Koski; Olli Taskinen; Minna Similä; Satu Männistö; Tiina Laatikainen; Paul Knekt; Liisa M Valsta Journal: Eur J Public Health Date: 2008-10-14 Impact factor: 3.367
Authors: Kirsten K Ness; K Scott Baker; Donald R Dengel; Nancy Youngren; Shalamar Sibley; Ann C Mertens; James G Gurney Journal: Pediatr Blood Cancer Date: 2007-12 Impact factor: 3.838
Authors: Kevin C Oeffinger; Ann C Mertens; Charles A Sklar; Yutaka Yasui; Thomas Fears; Marilyn Stovall; Terry A Vik; Peter D Inskip; Leslie L Robison Journal: J Clin Oncol Date: 2003-04-01 Impact factor: 50.717
Authors: Todd A Florin; G Edgar Fryer; Thomas Miyoshi; Michael Weitzman; Ann C Mertens; Melissa M Hudson; Charles A Sklar; Karen Emmons; Andrea Hinkle; John Whitton; Marilyn Stovall; Leslie L Robison; Kevin C Oeffinger Journal: Cancer Epidemiol Biomarkers Prev Date: 2007-07 Impact factor: 4.090
Authors: Jennifer A Hansen; Heather H Stancel; Lisa M Klesges; Vida L Tyc; Pamela S Hinds; Shengjie Wu; Melissa M Hudson; Lisa S Kahalley Journal: J Pediatr Oncol Nurs Date: 2014-01-22 Impact factor: 1.636
Authors: A Vatanen; M Hou; T Huang; O Söder; T Jahnukainen; M Kurimo; T H Ojala; T Sarkola; M Turanlahti; U M Saarinen-Pihkala; K Jahnukainen Journal: Bone Marrow Transplant Date: 2017-01-09 Impact factor: 5.483
Authors: Vesile Yildiz Kabak; Patrick Calders; Tulin Duger; Jibril Mohammed; Eric van Breda Journal: Support Care Cancer Date: 2018-09-25 Impact factor: 3.603
Authors: Kirsten K Ness; James P DeLany; Sue C Kaste; Daniel A Mulrooney; Ching-Hon Pui; Wassim Chemaitilly; Robyn E Karlage; Jennifer Q Lanctot; Carrie R Howell; Lu Lu; Deo Kumar Srivastava; Leslie L Robison; Melissa M Hudson Journal: Blood Date: 2015-03-26 Impact factor: 22.113
Authors: Matthew C Hocking; Lisa A Schwartz; Wendy L Hobbie; Branlyn Werba Derosa; Richard F Ittenbach; Jun J Mao; Jill P Ginsberg; Anne E Kazak Journal: Pediatr Blood Cancer Date: 2012-03-20 Impact factor: 3.167
Authors: Mitra Varedi; Lu Lu; Carrie R Howell; Robyn E Partin; Melissa M Hudson; Ching-Hon Pui; Kevin R Krull; Leslie L Robison; Kirsten K Ness; Raymond F McKenna Journal: J Clin Oncol Date: 2018-05-29 Impact factor: 44.544
Authors: Lindsey Christoffersen; Todd M Gibson; Ching-Hon Pui; Vijaya Joshi; Robyn E Partin; Daniel M Green; Jennifer Q Lanctot; Carrie R Howell; Daniel A Mulrooney; Gregory T Armstrong; Leslie L Robison; Melissa M Hudson; Kirsten K Ness Journal: Pediatr Blood Cancer Date: 2020-05-08 Impact factor: 3.167
Authors: Emily S Tonorezos; Peter G Snell; Chaya S Moskowitz; Debra A Eshelman-Kent; Jennifer E Liu; Joanne F Chou; Stephanie M Smith; Andrea L Dunn; Timothy S Church; Kevin C Oeffinger Journal: Pediatr Blood Cancer Date: 2013-02-15 Impact factor: 3.167
Authors: Kirsten K Ness; Sue C Kaste; Liang Zhu; Ching-Hon Pui; Sima Jeha; Paul C Nathan; Hiroto Inaba; Karen Wasilewski-Masker; Durga Shah; Robert J Wells; Robyn E Karlage; Leslie L Robison; Cheryl L Cox Journal: Leuk Lymphoma Date: 2014-08-20